checkAd
    Startseite > Aktien > Cellectis > Nachrichten
    Cellectis Aktie
    2,8200
     
    EUR
    -2,08 %
    -0,0600 EUR
    Letzter Kurs 10.05.24 Tradegate
    2,8000
     
    EUR
    196 STK
    Geldkurs 10.05.24
    2,8400
     
    EUR
    192 STK
    Briefkurs 10.05.24
    ISIN: US15117K1034 · WKN: A14QZE · SYM: ZVAA · Frankreich

    Neueste Nachrichten

    Monthly information on share capital and company voting rights
    06.05.24 · globenewswire · Cellectis Share
    Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
    06.05.24 · globenewswire · Cellectis Share
    Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
    02.05.24 · globenewswire · Cellectis Share
    Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
    29.04.24 · globenewswire · Cellectis Share
    Cellectis Presents Novel TALEN Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
    22.04.24 · globenewswire · Cellectis Share
    Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs
    10.04.24 · globenewswire · Cellectis Share
    Cellectis Announces Two Poster Presentations on Novel TALEN Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual Meeting
    08.04.24 · globenewswire · Cellectis Share
    Monthly information on share capital and company voting rights
    04.04.24 · globenewswire · Cellectis Share
    Monthly information on share capital and company voting rights
    04.03.24 · globenewswire · Cellectis Share
    Monthly information on share capital and company voting rights
    02.02.24 · globenewswire · Cellectis Share
    Cellectis announces the drawdown of the second tranche of €15 million under the credit facility agreement entered with the European Investment Bank (EIB)
    16.01.24 · globenewswire · Cellectis Share
    Monthly information on share capital and company voting rights
    08.01.24 · globenewswire · Cellectis Share